The Global Pharmaceutical Grade Sodium Bicarbonate Market is valued at US$ 265.3 million in 2023 and is projected to register significant growth at a CAGR of 3.5% to reach a market valuation of US$ 372.4 million by the end of 2033.
| Attribute | Details |
|---|---|
| Market Size (2023) | US$ 265.3 Million |
| Forecasted Market Size (2033) | US$ 372.4 Million |
| Value CAGR (2023 to 2033) | 3.5% |
| Collective Value Share: Top 5 Countries (2023E) | 55-59% |
According to this latest research conducted by Future Market Insights, global market revenue totaled US$ 256.0 million in 2022. The market is reliant on the pharmaceutical industry as a pH buffering agent, for electrolyte replenishing, as a systemic alkalizer, and in topical cleansing solutions. It is extensively used as an active pharmaceutical ingredient and excipient. The demand from hospitals, the personal care industry, and healthcare institutions is expected to benefit the global market.
| Market Statistics | Details |
|---|---|
| January–June (H1), 2021 (A) | 2.7% |
| July–December (H2), 2021 (A) | 3.3% |
| January–June (H1),2022 Projected (P) | 3.0% |
| January–June (H1),2022 Outlook (O) | 3.4% |
| July–December (H2), 2022 Outlook (O) | 3.1% |
| July–December (H2), 2022 Projected (P) | 3.6% |
| January–June (H1), 2023 Projected (P) | 3.6% |
| BPS Change : H1,2022 (O) - H1,2022 (P) | (+) 40 ↑ |
| BPS Change : H1,2022 (O) - H1,2021 (A) | (+) 70↑ |
| BPS Change: H2, 2022 (O) - H2, 2022 (P) | (-) 50 ↓ |
| BPS Change: H2, 2022 (O) - H2, 2021 (A) | (-) 20 ↓ |
The above chart depicts changes in the market owing to several global economic factors. The half-yearly analysis of the market provides investors with a short performance review for that specific period. Pharmaceutical industries were adapting to the immediate concerns brought on by supply chain disruption and the rapid need to modify healthcare procedures resulting in the loss of 50 BPS points in the year 2022. The market witnessed relatively lower demand owing to a disrupted supply of active chemicals and materials mainly from china which impacted the overall market.
Considerable growth in the pharmaceutical industry along with the increasing sales of chemicals is expected to boost the demand over the projected period. As per the latest estimations released by Future Market Insights (FMI), global sales is anticipated to increase swiftly between 2023 and 2033, creating an absolute growth opportunity of US$ 108.4 million.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The pharmaceutical Industry is the key consumer for sodium bicarbonate. The Covid-19 outbreak forced various pharma companies to shift their operation methods. The sudden spur in the adoption of new technologies and innovation to support virtual work as well as research and development efforts on possible treatment plans to balance the supply chain for medicines during a crisis has impacted the overall market during the pandemic.
The market is estimated to grow at 3.5% CAGR over the coming decade owing to advancements in research and developments, the transformation of digital platforms and IT is currently the top strategic priority for pharmaceutical companies and is expected to continue to be so in the future.
Pharmaceutical Grade Sodium Bicarbonate is expected to register significant growth during the assessment period. Based on geography East Asia is estimated to dominate the market owing to the presence of a leading manufacturing units of leading pharmaceutical companies in China.
Over the past five years, numerous developments in the market have taken place. Leading Companies devised their plans to fend off possible threats and seize the medium- and long-term possibilities presented by this shifting environment and focused on the development of soda bicarbonate drugs with a fine grade for the treatment of a wide range of diseases.
Active pharmaceutical ingredients are the chemical compounds in medicines that have a significant effect on the body, such drugs containing soda-bicarbonate help in activate an anti-inflammatory pathway and prevent autoimmune diseases. Some medicines called OTC (over-the-counter) medicines contained pharma-grade baking soda as an active pharma ingredient.
Over-the-counter drugs are medicines that can be bought without a prescription as per the guidelines issued by FDA (Food and Drug Administration), which considers them safe for use without medical supervision. These drugs are used to treat various generic health problems such as sleeping-related problems, cough and cold, pain, smoking cessation, itches, weight problems, tooth decay, gastrointestinal problems, and various others.
The top five over-the-counter categories include — cough-cold and allergy, vitamins, weight loss and nutrition, pain relief, and digestives — which collectively accounted for a significant share of all over-the-counter sales in 2022.
Antacids are one of the most popular over-the-counter medicines. Consistent growth in sales of antacids, baking soda or sodium bicarbonate is the key ingredient for any kind of antacids. Steady growth in sales of antacids is promoting the demand with consistent growth rates.
Awareness and media advertising made people aware about self-medication for occasional heartburn and acidity and the availability of antacids in over-the-counter (OTC) sales has emerged as one of the prime factors for antacids and similar products’ growth.
Principal Consultant
The production of many different products involves the use of sodium carbonate in a range of chemical processes, particularly acid-base reactions. They could be found in many personal care products, including toothpaste, which temporarily raises the pH level of the mouth by acting as abrasives or foaming agents.
Hair dyes also contain pharma-grade sodium carbonate. It eliminates oil and grime from the skin and hair while also assisting with pH control. Pharma-grade baking soda is used by several organizations in the personal care industry. For instance, Church and Dwight Co. Inc. utilizes sodium carbonate in their dental pastes whereas Proctor and Gamble Co. uses it in their men's hair color products.
The growing demand from the personal care and cosmetics industry for active ingredients in formulations is expected to boost the demand for pharma-grade baking soda during the forecast period.
Active pharmaceutical ingredients are the leading application segment of the sodium bicarbonate market and are estimated to dominate the global market, accounting for nearly 33.2% of the market by 2033.
An active pharmaceutical ingredient, or API, is the main component of medicine. It is mostly accountable for enhancing the drug's ability to treat diseases and their associated symptoms. Several organizations in the pharmaceutical industry utilize sodium carbonate as API to improve the efficacy of their products.
The urgent need for small molecules which are considered to be an integral part of prescription drugs for secondary treatment issued by a specialist is another vital factor that is likely to bolster the sales of active pharma ingredients.
On the basis of grade, the fine grade segment is the most preferred grade of baking soda and is estimated to dominate the global market, accounting for nearly 20.7% of the market by 2033.
Unlike traditional medicines, baking soda tablets are fast-acting antacids. They are used for instant relief in case of heartburn and indigestion. These tablets can easily dissolve in water before consumption owing to the presence of fine particles of soda bi-carbonate.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Country | United States |
|---|---|
| Market Share (2023) | 21.9% |
| Market Share (2033) | 20.6% |
| BPS Analysis | -128.0 |
| Country | China |
|---|---|
| Market Share (2023) | 23.8% |
| Market Share (2033) | 25.6% |
| BPS Analysis | +177.6 |
| Country | Germany |
|---|---|
| Market Share (2023) | 8.1% |
| Market Share (2033) | 8.2% |
| BPS Analysis | +10 |
| Country | Japan |
|---|---|
| Market Share (2023) | 5.5% |
| Market Share (2033) | 5.2% |
| BPS Analysis | -28.4 |
| Country | India |
|---|---|
| Market Share (2023) | 3.3% |
| Market Share (2033) | 3.5% |
| BPS Analysis | +23.4 |
China holds more than 23.8% of the volume and value share in the global market which is likely to remain unchanged through the forecast period. Key players from China have significant opportunities to leverage revenue generation in the country.
Chinese pharmaceutical manufacturers have largely focused on the production of basic chemicals, intermediates, and active pharmaceutical ingredients (APIs), with roughly 4,000 API manufacturers in the country. Thus, an increase in the production of active pharmaceutical ingredients drives the demand for the soda-bicarbonate market.
In India, there is a high concentration of manufacturers of pharma drugs and vaccines, which is contributing to the growth of the market in this region at a CAGR of 3.8% through 2033.
The generic medications produced in India and distributed internationally offer safety and quality. India accounts for the second-most portion of the global workforce in biotechnology and pharmaceuticals. The biotechnology sector in India, which includes biopharmaceuticals, services, bio-agriculture, bio-industry, and bioinformatics, is predicted to develop at an average pace of 30% and reach US$ 100 billion by 2025.
Various online or telemarketing campaigns is informing Indian consumers towards the ineffectiveness of traditional home remedies and generic solutions like lime juice. Such innovative advertising initiatives by well-known businesses is expected to increase product consumption in India.
Germany holds a 33.9% share in the Western Europe market, while also holding a leading position in global market. Germany is the ideal location for pharmaceutical research and development, manufacture, and sales due to cutting-edge research and innovation facilities, long history as the "world's pharmacy," and consistently high demand for healthcare products which is expected to propel the demand for pharmaceutical-grade sodium bicarbonate in the country.
According to The Observatory of Economics, in 2020, Germany exported US$116 million in baking, making it the 2nd largest exporter of baking soda in the world. The surge in the production of baking soda in Germany is expected to boost demand for the market during the forecast period.
The market is concentrated by leading manufacturers. Tier-I companies are focused on developing high-quality pharma-grade-baking soda and developing technologies for mining. Leading players in the market are focusing on generating revenue by exploring potential applications. Players are expanding their geographical boundaries to them expand their consumer base.
Key Developments:
| Attribute | Details |
|---|---|
| Growth Rate | CAGR of 3.5% from 2023 to 2033 |
| Base Year for Estimation | 2023 |
| Historical Data | 2018 to 2022 |
| Forecast Period | 2023 to 2033 |
| Quantitative Units | Revenue in USA Dollar Million, Volume in Tons, and CAGR from 2023 to 2033 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Market Segments Covered |
|
| Regions Covered |
|
| Key Countries Covered |
|
| Key Companies Profiled |
|
| Customization and Pricing | Available upon Request |
The market registered 4.1% HCAGR from 2013 to 2021.
The market is estimated to US$ 315.4 million by 2028.
Through 2028, the market is anticipated to expand at a 3.5% CAGR.
The API category is expected to capture 31.9% of the market share.
The fine sector is projected to maintain its lead.
1. Executive Summary | Pharmaceutical Grade Sodium Bicarbonate Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Product innovation and Diversification
4.3. Marketing and Brand management
4.4. Supply Chain Management
5. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033
5.1. Historical Market Volume (Tons) Analysis, 2018 to 2022
5.2. Current and Future Market Volume (Tons) Projections, 2023 to 2033
5.3. Y-o-Y Growth Trend Analysis
6. Global Market - Pricing Analysis
6.1. Pricing Analysis by Grade
6.2. Pricing Break-up
6.3. Global Average Pricing Analysis Benchmark
7. Global Market Demand (in Value or Size in US$ Million) Analysis 2018 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Value (US$ Million) Analysis, 2018 to 2022
7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Macro-Economic Factors
8.2. Forecast Factors - Relevance and Impact
8.3. Value Chain Analysis
8.4. Porter’s Five Analysis
8.5. Supply Demand Overview
8.6. Buyer’s Decision Rationale
8.7. Market Dynamics
8.7.1. Drivers
8.7.2. Restraints
8.7.3. Opportunity Analysis
8.8. Impact of COVID – 19 Crisis
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Grade
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume Analysis by Grade, 2018 to 2022
9.3. Current and Future Market Size (US$ Million) and Volume Analysis and Forecast by Grade, 2023 to 2033
9.3.1. Fine
9.3.2. Coarse
9.4. Market Attractiveness Analysis by Grade
10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) and Volume Analysis by Application, 2018 to 2022
10.3. Current and Future Market Size (US$ Million) and Volume Analysis and Forecast by Application, 2023 to 2033
10.3.1. API
10.3.2. Excipients
10.3.3. Antacids
10.3.4. Haemodialysis
10.3.5. Tablet Coating
10.3.6. Toothpaste
10.3.7. Others
10.4. Market Attractiveness Analysis by Application
11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Million) and Volume Analysis by Region, 2018 to 2022
11.3. Current Market Size (US$ Million) and Volume Analysis and Forecast by Region, 2023 to 2033
11.3.1. North America
11.3.2. Latin America
11.3.3. Eastern Europe
11.3.4. Western Europe
11.3.5. South East Asia and Pacific
11.3.6. China
11.3.7. India
11.3.8. Japan
11.3.9. Middle East and Africa
11.4. Market Attractiveness Analysis by Region
12. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2018 to 2022
12.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2023 to 2033
12.4.1. by Grade
12.4.2. by Application
12.4.3. by Country
12.4.3.1. USA
12.4.3.2. Canada
12.5. Market Attractiveness Analysis
12.5.1. by Grade
12.5.2. by Application
12.5.3. by Country
12.6. Market Trends
12.7. Driver and Restraint: Impact Analysis
13. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2018 to 2022
13.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2023 to 2033
13.4.1. by Grade
13.4.2. by Application
13.4.3. by Country
13.4.3.1. Brazil
13.4.3.2. Mexico
13.4.3.3. Rest of Latin America
13.5. Market Attractiveness Analysis
13.5.1. by Grade
13.5.2. by Application
13.5.3. by Country
13.6. Market Trends
13.7. Driver and Restraint: Impact Analysis
14. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2018 to 2022
14.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2023 to 2033
14.4.1. by Grade
14.4.2. by Application
14.4.3. by Country
14.4.3.1. Russia
14.4.3.2. Poland
14.4.3.3. Rest of Eastern Europe
14.5. Market Attractiveness Analysis
14.5.1. by Grade
14.5.2. by Application
14.5.3. by Country
14.6. Market Trends
14.7. Driver and Restraint: Impact Analysis
15. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2018 to 2022
15.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2023 to 2033
15.4.1. by Grade
15.4.2. by Application
15.4.3. by Country
15.4.3.1. Germany
15.4.3.2. Italy
15.4.3.3. France
15.4.3.4. United Kingdom
15.4.3.5. Spain
15.4.3.6. Rest of Western Europe
15.5. Market Attractiveness Analysis
15.5.1. by Grade
15.5.2. by Application
15.5.3. by Country
15.6. Market Trends
15.7. Driver and Restraint: Impact Analysis
16. China Market Analysis 2018 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2018 to 2022
16.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2023 to 2033
16.4.1. by Grade
16.4.2. by Application
16.5. Market Attractiveness Analysis
16.5.1. by Grade
16.5.2. by Application
16.5.3. by Country
16.6. Market Trends
16.7. Driver and Restraint: Impact Analysis
17. Japan Market Analysis 2018 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2018 to 2022
17.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2023 to 2033
17.4.1. by Grade
17.4.2. by Application
17.5. Market Attractiveness Analysis
17.5.1. by Grade
17.5.2. by Application
17.5.3. by Country
17.6. Market Trends
17.7. Driver and Restraint: Impact Analysis
18. India Market Analysis 2018 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2018 to 2022
18.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2023 to 2033
18.4.1. by Grade
18.4.2. by Application
18.4.3. by Country
18.5. Market Attractiveness Analysis
18.5.1. by Grade
18.5.2. by Application
18.5.3. by Country
18.6. Market Trends
18.7. Driver and Restraint: Impact Analysis
19. South East Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2018 to 2022
19.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2023 to 2033
19.4.1. by Grade
19.4.2. by Application
19.4.3. by Country
19.4.3.1. Oceania
19.4.3.2. Association of South East Asian Nations
19.4.3.3. Rest of South Asia and Pacific
19.5. Market Attractiveness Analysis
19.5.1. by Grade
19.5.2. by Application
19.5.3. by Country
19.6. Market Trends
19.7. Driver and Restraint: Impact Analysis
20. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Million) and Volume Trend Analysis by Market Taxonomy, 2018 to 2022
20.4. Market Size (US$ Million) and Volume Forecast by Market Taxonomy, 2023 to 2033
20.4.1. by Grade
20.4.2. by Application
20.4.3. by Country
20.4.3.1. Gulf Cooperation Council Countries
20.4.3.2. Türkiye
20.4.3.3. Northern Africa
20.4.3.4. South Africa
20.4.3.5. Rest of Middle East and Africa
20.5. Market Attractiveness Analysis
20.5.1. by Grade
20.5.2. by Application
20.5.3. by Country
20.6. Market Trends
20.7. Driver and Restraint: Impact Analysis
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Concentration
21.3. Market Share Analysis of Top Players
21.4. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Key Developments
22.4. Competition Deep Dive
22.4.1. Solvay SA
22.4.1.1. Overview
22.4.1.2. Product Portfolio
22.4.1.3. Sales Footprint
22.4.1.4. Strategy Overview
22.4.2. Tata Chemicals
22.4.2.1. Overview
22.4.2.2. Product Portfolio
22.4.2.3. Sales Footprint
22.4.2.4. Strategy Overview
22.4.3. Novacarb (Novacap Group)
22.4.3.1. Overview
22.4.3.2. Product Portfolio
22.4.3.3. Sales Footprint
22.4.3.4. Strategy Overview
22.4.4. Dr. Paul Lohmann GmbH KG
22.4.4.1. Overview
22.4.4.2. Product Portfolio
22.4.4.3. Sales Footprint
22.4.4.4. Strategy Overview
22.4.5. GHCL Limited
22.4.5.1. Overview
22.4.5.2. Product Portfolio
22.4.5.3. Sales Footprint
22.4.5.4. Strategy Overview
22.4.6. CIECH S.A.
22.4.6.1. Overview
22.4.6.2. Product Portfolio
22.4.6.3. Sales Footprint
22.4.6.4. Strategy Overview
22.4.7. Natural Soda LLC
22.4.7.1. Overview
22.4.7.2. Product Portfolio
22.4.7.3. Sales Footprint
22.4.7.4. Strategy Overview
22.4.8. Jost Chemical Co.
22.4.8.1. Overview
22.4.8.2. Product Portfolio
22.4.8.3. Sales Footprint
22.4.8.4. Strategy Overview
22.4.9. Tornox Alkali Corporation
23. Assumptions and Acronyms Used
24. Research Methodology
Chemicals & Materials
July 2023
REP-GB-1701
333 pages
Explore Chemicals & Materials Insights
View Reports
Pharmaceuticals Grade Sodium Bicarbonate Market
